LGT209: Clinical Trials

1 trial of LGT209, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow LGT209: new trials by email Literature Review of LGT209 trials Research Report on LGT209

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety, Tolerability, PK and PD of LGT209 in Healthy Volunteers and Patients With Hypercholesterolemia
LGT209, Placebo - Hypercholesterolemia
Phase 1CompletedNovartis Pharmaceuticals742010-12-012013-12-10

Conditions studied

Hypercholesterolemia (1)  ·  Hypercholesterolemia, Autosomal Dominant, 3 (1)

Sponsors

Novartis Pharmaceuticals (1)

Countries

United States (1)